Common Contracts

THERAVANCE, INC. COMMON STOCK PURCHASE AGREEMENT July 30, 2013

Common Stock Purchase Agreement • July 30th, 2013 • Theravance Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Common Stock Purchase Agreement
• Filed
  July 30th, 2013
• Company
  Theravance Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of the 30th day of July, 2013, by and among Theravance, Inc., a Delaware corporation (the “Company”), Glaxo Group Limited, a limited liability company organized under the laws of England and Wales (the “Investor”), and solely for the purposes of Sections 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.9, 6.10, 6.11, 6.12, 6.13, 6.14, 6.17 and 6.18 hereof, GlaxoSmithKline LLC, a Delaware limited liability company, the successor entity to SmithKline Beecham Corporation, a Pennsylvania corporation (“GSK”).

THERAVANCE, INC. COMMON STOCK PURCHASE AGREEMENT [date]

Common Stock Purchase Agreement • May 4th, 2011 • Theravance Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Common Stock Purchase Agreement
• Filed
  May 4th, 2011
• Company
  Theravance Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of the day of , by and among Theravance, Inc., a Delaware corporation (the “Company”), Glaxo Group Limited, a limited liability company organized under the laws of England and Wales (the “Investor”), and solely for the purposes of Sections 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.9, 6.10, 6.11, 6.12, 6.13, 6.14, 6.17 and 6.18 hereof, GlaxoSmithKline LLC, a Delaware limited liability company, the successor entity to SmithKline Beecham Corporation, a Pennsylvania corporation (“GSK”).